TXNRD1 and central nervous system cancer: Since human and rat MDR glioma cell lines possess different antioxidative capacities (Stankovic et al., 2015; Stojkovic et al., 2015), we aimed to compare their vulnerability to oxidative stress induced by TrxR1 inhibitors.